Research advancement and growth was clearly evident at GenesisCare in 2019. We engaged various industry partners to perform world-firsts in cardiac procedures and advance cancer treatments under the remarkable leadership of Prof. Stephen Worthley (Cardiology) and A/Prof. Peter O’Brien (Oncology). Our research division has been bolstered by dedicated and globally placed research teams who have recognized and overcome the challenges of our various research activities. Their efforts are evident by the increased number of clinical trials and the substantial growth of real-world evidence in our clinical registries.
